McGill researchers have developed a diagnostic system capable of identifying bacteria—and determining which antibiotics can ...

Opportunistic infections can contribute to antimicrobial resistance making these infections more severe than would occur otherwise. Some uninvolved pathogens that cause these infections possess ...

Whether you’re a sensitive-skinned beginner or an experienced retinol user, we researched the market’s top retinol serums to bring you our favorites of 2026.

Preliminary year-end cash and cash equivalents of approximately $466 million; projected revenues, cash and cash equivalents expected to be sufficient to fund operations to profitability WALTHAM, Mass.

You’ve surely heard of probiotics, which can help maintain a healthy gut for better digestion, nutrient absorption and immune support. But a budding class of probiotics called “psychobiotics” is being ...

WALTHAM, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that The New England Journal of Medicine (NEJM) published positive results from the Phase ...

Bacterial solutions have been studied to promote self-healing of cementitious matrices, however, the concentration of this solutions varied between studies. Consequently, the objective of this study ...

Researchers have developed and validated a heat transfer model that accurately predicts the survival of encapsulated bacteria in self-healing concrete exposed to high temperatures during fires. Study: ...

The FDA has approved pegcetacoplan (Empaveli, Apellis Pharmaceuticals, Inc.) for the treatment of C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) ...

“I’m excited to now have a highly effective therapy for a broad range of patients living with C3G and primary IC-MPGN,” said Carla Nester, M.D., MSA, FASN, lead principal investigator for the VALIANT ...

WALTHAM, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals (APLS), Inc. (Nasdaq: APLS), today announced its first quarter 2025 financial results and business highlights. “In the first ...